MediPharm Labs Corp. specializes in the production and manufacturing of high-quality cannabinoid-based derivatives and pharmaceutical ingredients. The company operates as a full-service pharmaceutical entity, focusing on the industrial-scale manufacturing of cannabinoid products that meet pharmaceutical standards. MediPharm Labs sources dried cannabis from legal producers and employs advanced extraction and purification techniques to create cannabis extracts for both domestic and international markets. Its operations are based in Canada and Australia, where it holds various licenses for manufacturing and distributing cannabis-based medicines and active pharmaceutical ingredients.
